Clinical Trials Directory

Trials / Completed

CompletedNCT02433951

Exercise Tolerance in Patients With CABG and Sternotomy vs. Patients With Minimally Invasive Coronary Surgery

Exercise Tolerance in Patients With Coronary Artery Bypass Surgery (CABG) and Sternotomy vs. Patients With Minimally Invasive Coronary Surgery

Status
Completed
Phase
Study type
Observational
Enrollment
55 (actual)
Sponsor
Hasselt University · Academic / Other
Sex
All
Age
40 Years – 85 Years
Healthy volunteers
Accepted

Summary

In this study, up to 20 healthy individuals, 20 endo-ACAB patients, and 20 CABG patients undergo a maximal cardiopulmonary exercise test after hospital discharge (for patients only). Exercise tolerance is compared between groups.

Detailed description

In this prospective observational study, up to 20 healthy individuals (no history or presence of any chronic disease, sedentary), 20 endo-ACAB patients, and 20 CABG patients (matched for age, gender and BMI) undergo a maximal cardiopulmonary exercise test after hospital discharge (for patients only).During this exercise test, following parameters are assessed at peak effort and at the second ventilatory threshold (determined by VE/VCO2 slope method): oxygen uptake (VO2), oxygen saturation (SaO2), carbon dioxide output (VCO2), resoiratory gas exchange ratio (RER), expiratory volume (VE), ventilatory equivalent for VCO2 (VE/VCO2), ventilatory equivalent for VO2 (VE/VO2), end-tidal O2 pressure (PETO2), end-tidal CO2 pressure (PETCO2), heart rate (HR), oxygen pulse (VO2/HR), cycling power output (W), tidal volume (Vt), respiratory rate (RR), systolic blood pressure (SBP), diastolic blood pressure (DBP), rate pressure product (RPP). Peak exercise effort is validated by RERpeak.

Conditions

Interventions

TypeNameDescription
OTHERCardiopulmonary exercise testMaximal exercise test with ergospirometry.

Timeline

Start date
2015-02-01
Primary completion
2015-06-01
Completion
2015-07-01
First posted
2015-05-05
Last updated
2015-08-19

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT02433951. Inclusion in this directory is not an endorsement.